Zhang Wang, Wu Lele, Qu Ru, Liu Tianfeng, Wang Jiliang, Tong Ying, Bei Weijian, Guo Jiao, Hu Xuguang
Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Heliyon. 2024 Aug 2;10(16):e35424. doi: 10.1016/j.heliyon.2024.e35424. eCollection 2024 Aug 30.
BACKGROUND AND AIMS: In all age, FoShou as a Chinese medicinal herb has been active in various kinds of Traditional Chinese medicine formula to treating diabetes. Hesperidin (HES), the main monomeric component of FoShou, has been extensively investigated for interventions with pathogenic mechanism of diabetes as well as subsequent treatment of associated complications. Islet β-cells have an essential effect on dynamically regulating blood sugar. Functional abnormalities in these cells and their death are strongly associated with the onset of diabetes. Therefore, induction of islet endocrine cell lineage re-editing for damaged βcell replenishment would be a promising therapeutic tool. Previously, it has been found that HES can protect islet β-cells in vivo, But, the regenerative function of HES in islet β cells and its role in promoting differential non-β cells transdifferentiation into β cells and cell fate rewriting associated mechanisms remain unclear.This work focused on investigating whether HES can induce islet α cells transdifferentiation into β cells for achieving damaged β cell regeneration and the causes and possible mechanisms involved in the process. MATERIALS AND METHODS: In brief, 60 mg/kg/d streptozotocin (STZ) was administered intraperitoneally in each male C57bL/6J mouse raised by the high-sugar and high-fat diet (HFD) to create a diabetic mouse model with severe β-cell damage. After 28 consecutive days of HES treatment (160 mg/kg; 320 mg/kg; once daily, as appropriate). Tracing the dynamics of α as well as β cell transformation, together with β cells growth and apoptosis levels during treatment by cell lineage tracing. The self-enforcing transcriptional network on which the cell lineage is based is used as a clue to explore the underlying mechanisms. Guangdong Pharmaceutical University's Animal Experiment Ethics Committee (GDPulac2019180) approved all animal experiments. RESULTS: Localization by cell lineage we find that transdifferentiated newborn β-cells derived from α cells appeared in the islet endocrine cell mass of DM mice under HES'action. Compared to the model group, expressed by Tunel staining and CXCL10 levels the overall apoptosis rate of β-cells of the pancreas were reduced,the inflammatory infiltration feedback from HE staining were lower.Ki-67 positive cells showed enhanced β-cell proliferation. Decreased HbA1c and blood glucose contents, elevated C-Peptide and insulin contents which respond to ability of nascent beta cells. Also upregulated the mRNA levels of MafA, Ngn3, PDX-1, Pax4 and Arx. Moreover, increased the expression of TGR5/cAMP-CREB/GLP-1 in mouse intestinal tissues and GLP-1/GLP-1R and cAMP-CREB/IRS2/PDX-1 in pancreatic tissues. CONCLUSIONS: HES directly affects β-cells, apart from being anti-apoptotic and reducing inflammatory infiltration. HES promotes GLP-1 release by intestinal L cells by activating the TGR5 receptor in DM mouse and regulating its response element CREB signaling. GLP-1 then uses the GLP-1/GLP-1R system to act on IRS2, IRS2 as a port to influence α precursor cells to express PDX-1, with the mobilization of Pax4 strong expression than Arx so that α cell lineage is finally reversed for achieving β cell endogenous proliferation.
背景与目的:佛手作为一种中药材,在各年龄段均被应用于多种治疗糖尿病的中药方剂中。橙皮苷(HES)是佛手的主要单体成分,已针对糖尿病发病机制的干预及相关并发症的后续治疗进行了广泛研究。胰岛β细胞对动态调节血糖起着至关重要的作用。这些细胞的功能异常及其死亡与糖尿病的发生密切相关。因此,诱导胰岛内分泌细胞谱系重编辑以补充受损的β细胞将是一种有前景的治疗手段。此前已发现HES可在体内保护胰岛β细胞,但是,HES在胰岛β细胞中的再生功能及其在促进非β细胞向β细胞转分化以及细胞命运重写相关机制中的作用仍不清楚。本研究聚焦于探究HES是否能诱导胰岛α细胞转分化为β细胞以实现受损β细胞的再生以及该过程中涉及的原因和可能机制。 材料与方法:简而言之,对采用高脂高糖饮食(HFD)饲养的每只雄性C57bL/6J小鼠腹腔注射60mg/kg/d链脲佐菌素(STZ),以建立严重β细胞损伤的糖尿病小鼠模型。连续28天给予HES治疗(160mg/kg;320mg/kg;每日一次,酌情使用)。通过细胞谱系追踪来追踪治疗期间α细胞以及β细胞转化的动态变化,以及β细胞的生长和凋亡水平。以细胞谱系所基于的自我强化转录网络为线索来探究潜在机制。广东药科大学动物实验伦理委员会(GDPulac2019180)批准了所有动物实验。 结果:通过细胞谱系定位,我们发现在HES作用下,糖尿病小鼠的胰岛内分泌细胞团中出现了源自α细胞的转分化新生β细胞。与模型组相比,通过Tunel染色和CXCL10水平表明胰腺β细胞的总体凋亡率降低,HE染色显示的炎症浸润反馈较低。Ki-67阳性细胞显示β细胞增殖增强。糖化血红蛋白(HbA1c)和血糖含量降低,反映新生β细胞功能的C肽和胰岛素含量升高。同时,MafA、Ngn3、PDX-1、Pax4和Arx的mRNA水平上调。此外,小鼠肠道组织中TGR5/cAMP-CREB/GLP-1的表达增加,胰腺组织中GLP-1/GLP-1R以及cAMP-CREB/IRS2/PDX-1的表达增加。 结论:HES除了具有抗凋亡和减少炎症浸润作用外,还直接影响β细胞。HES通过激活糖尿病小鼠肠道L细胞中的TGR5受体并调节其反应元件CREB信号来促进GLP-1释放。然后,GLP-1利用GLP-1/GLP-1R系统作用于IRS2,IRS2作为一个端口影响α前体细胞表达PDX-1,同时Pax4的表达强于Arx的调动,从而最终逆转α细胞谱系以实现β细胞的内源性增殖。
Biochem Soc Trans. 2021-12-17
Nat Metab. 2021-2
Biomed Pharmacother. 2019-1-8
Stem Cell Res Ther. 2017-11-2